Targeting the Pathogenic Role of Interleukin 1[beta] in the Progression of Smoldering/Indolent Myeloma to Active Disease

Charles A Dinarello

首页> 外文期刊>Mayo Clinic Proceedings >Targeting the Pathogenic Role of Interleukin 1[beta] in the Progression of Smoldering/Indolent Myeloma to Active Disease

【24h】

Targeting the Pathogenic Role of Interleukin 1[beta] in the Progression of Smoldering/Indolent Myeloma to Active Disease

机译：靶向白介素1β在闷烧/惰性骨髓瘤向活动性疾病进展中的致病作用

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Mayo Clinic Proceedings》 |2009年第2期|p.105-107|共3页
作者
Charles A Dinarello;
展开▼
作者单位

Supported by National Institutes of Health grants AI15614 and CA04 6934.Address correspondence to Charles A. Dlnarello, MD, Department of Medicine, Division of Infectious Diseases, University of Colorado Denver, 12700 E 19th Ave, B168, Aurora, CO 80045 (cdlnare333@aol.com).© 2009 Mayo Foundation for Medical Education and ResearchCharles A. Dinarello, MDDepartment of MedicineDivision of Infectious DiseasesUniversity of Colorado DenverAurora;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Targeting the Pathogenic Role of Interleukin 1beta in the Progression of Smoldering/Indolent Myeloma to Active Disease [J] . Charles A. Dinarello Mayo Clinic Proceedings . 2009,第2期

机译：针对白细胞介素1β的致病作用，将其闷烧/惰性骨髓瘤发展为活动性疾病
2. Induction of a Chronic Disease State in Patients With Smoldering or Indolent Multiple Myeloma by Targeting Interleukin 1[beta]-Induced Interleukin 6 Production and the Myeloma Proliferative Component [J] . John A Lust Martha Q Lacy Steven R Zeldenrust Angela Dispenzieri Morie A Gertz Thomas E Witzig Shaji Kumar Suzanne R Hayman Stephen J Russell Francis K Buadi Susan M Geyer Megan E Campbell Robert A Kyle S Vincent Rajkumar Philip R Greipp Mayo Clinic Proceedings . 2009,第2期

机译：通过靶向白细胞介素1β诱导的白细胞介素6的产生和骨髓瘤增殖成分，在闷热或惰性多发性骨髓瘤患者中诱导慢性疾病状态
3. Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component. [J] . Lust JA, Lacy MQ, Zeldenrust SR, Mayo Clinic Proceedings . 2009,第2期

机译：通过靶向白介素1β诱导的白介素6的产生和骨髓瘤增殖成分，在闷热或惰性多发性骨髓瘤患者中诱导慢性疾病状态。
4. Blocking IL-1 Beta to Prevent Progression to Multiple Myeloma [C] . Lust J. Donovan K. Joint Conferences of the International Cytokine Society and the International Society for Interferon and Cytokine Research . 2011

机译：阻断IL-1β以防止进展到多个骨髓瘤
5. CD166 modulates disease progression and osteolytic disease in multiple myeloma. [D] . Xu, Linlin. 2016

机译：CD166调节多发性骨髓瘤的疾病进展和溶骨性疾病。
6. Targeting the Pathogenic Role of Interleukin 1β in the Progression of Smoldering/Indolent Myeloma to Active Disease [O] . Charles A. Dinarello 2009

机译：靶向白介素1β在闷烧/惰性骨髓瘤向活动性疾病进展中的致病作用
7. 18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease [O] . E Zamagni, C Nanni, F Gay, 2015

机译：18F-FDG宠物/ CT局灶性，但不是骨解，病变预测将骨髓瘤闷闷马瘤的进展预测到活性疾病
8. Role of the TGFbeta Pathway in Prostate Cancer Progression to an Androgen-Independent Disease [R] . Matusik, R. J. 2002

机译：TGFbeta途径在前列腺癌进展为雄激素非依赖性疾病中的作用

Targeting the Pathogenic Role of Interleukin 1[beta] in the Progression of Smoldering/Indolent Myeloma to Active Disease

著录项

相似文献

相关主题

期刊订阅